Home LiteratureArticle Details
PMID: 24025110 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Building a better dynasore: the dyngo compounds potently inhibit dynamin and endocytosis.

Traffic (Copenhagen, Denmark) ·Vol. 14 ·No. 12 ·2013-12-00 ·Pages 1272-89

McCluskey A, Daniel JA, Hadzic G, Chau N, Clayton EL, Mariana A, Whiting A, Gorgani NN, Lloyd J, Quan A, Moshkanbaryans L, Krishnan S, Perera S, Chircop M, von Kleist L, McGeachie AB, Howes MT, Parton RG, Campbell M, Sakoff JA, Wang X, Sun JY, Robertson MJ, Deane FM, Nguyen TH, Meunier FA, Cousin MA, Robinson PJ

Abstract

Dynamin GTPase activity increases when it oligomerizes either into helices in the presence of lipid templates or into rings in the presence of SH3 domain proteins. Dynasore is a dynamin inhibitor of moderate potency (IC₅₀ ~ 15 μM in vitro). We show that dynasore binds stoichiometrically to detergents used for in vitro drug screening, drastically reducing its potency (IC₅₀ = 479 μM) and research tool utility. We synthesized a focused set of dihydroxyl and trihydroxyl dynasore analogs called the Dyngo™ compounds, five of which had improved potency, reduced detergent binding and reduced cytotoxicity, conferred by changes in the position and/or number of hydroxyl substituents. The Dyngo compound 4a was the most potent compound, exhibiting a 37-fold improvement in potency over dynasore for liposome-stimulated helical dynamin activity. In contrast, while dynasore about equally inhibited dynamin assembled in its helical or ring states, 4a and 6a exhibited >36-fold reduced activity against rings, suggesting that they can discriminate between helical or ring oligomerization states. 4a and 6a inhibited dynamin-dependent endocytosis of transferrin in multiple cell types (IC₅₀ of 5.7 and 5.8 μM, respectively), at least sixfold more potently than dynasore, but had no effect on dynamin-independent endocytosis of cholera toxin. 4a also reduced synaptic vesicle endocytosis and activity-dependent bulk endocytosis in cultured neurons and synaptosomes. Overall, 4a and 6a are improved and versatile helical dynamin and endocytosis inhibitors in terms of potency, non-specific binding and cytotoxicity. The data further suggest that the ring oligomerization state of dynamin is not required for clathrin-mediated endocytosis.

Keywords
bulk endocytosis drug discovery dynamin high-throughput screening small-molecule inhibitors synaptic vesicle endocytosis
MeSH Terms
Animals Cell Line, Tumor Cells, Cultured Cholera Toxin/metabolism Dose-Response Relationship, Drug Drug Discovery Dynamins/antagonists & inhibitors,metabolism Endocytosis/drug effects High-Throughput Screening Assays Humans Hydrazones/chemical synthesis,chemistry,pharmacology Naphthols/chemistry,pharmacology Neurons/drug effects,metabolism Protein Binding Protein Transport Rats Rats, Sprague-Dawley Sheep Synaptic Vesicles/drug effects,metabolism Transferrins/metabolism
Chemicals
Hydrazones N'-(3,4-dihydroxybenzylidene)-3-hydroxy-2-naphthahydrazide Naphthols Transferrins dyngo-4a Cholera Toxin Dynamins
Authors & Affiliations
28 authors, click to expand affiliations / ORCID
McCluskey Adam
Chemistry, Centre for Chemical Biology, School of Environmental and Life Sciences, The University of Newcastle, Callaghan, NSW, 2308, Australia.
Daniel James A
Hadzic Gordana
Chau Ngoc
Clayton Emma L
Mariana Anna
Whiting Ainslie
Gorgani Nick N
Lloyd Jonathan
Quan Annie
Moshkanbaryans Lia
Krishnan Sai
Perera Swetha
Chircop Megan
von Kleist Lisa
McGeachie Andrew B
Howes Mark T
Parton Robert G
Campbell Michael
Sakoff Jennette A
Wang Xuefeng
Sun Jian-Yuan
Robertson Mark J
Deane Fiona M
Nguyen Tam H
Meunier Frederic A
Cousin Michael A
Robinson Phillip J
References (63)
63 references, click to expand
  1. Ba2+ does not support synaptic vesicle retrieval in rat cerebrocortical synaptosomes.
    Neurosci Lett. 1998 Aug 28;253(1):1-4 PMID: 9754790
  2. Synaptosomes possess an exocytotic pool of glutamate.
    Nature. 1986 Jun 19-25;321(6072):772-3 PMID: 3713864
  3. Inhibition of dynamin completely blocks compensatory synaptic vesicle endocytosis.
    Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17955-60 PMID: 17093049
  4. Ca(2+) influx inhibits dynamin and arrests synaptic vesicle endocytosis at the active zone.
    J Neurosci. 2000 Feb 1;20(3):949-57 PMID: 10648699
  5. Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism.
    J Biol Chem. 2011 Oct 14;286(41):35966-35976 PMID: 21832053
  6. Fast kinetics of exocytosis revealed by simultaneous measurements of presynaptic capacitance and postsynaptic currents at a central synapse.
    Neuron. 2001 Apr;30(1):171-82 PMID: 11343653
  7. Dynasore, a cell-permeable inhibitor of dynamin.
    Dev Cell. 2006 Jun;10(6):839-50 PMID: 16740485
  8. Activity-dependent bulk synaptic vesicle endocytosis--a fast, high capacity membrane retrieval mechanism.
    Mol Neurobiol. 2009 Jun;39(3):185-9 PMID: 19266323
  9. Regulation of dynamin-2 assembly-disassembly and function through the SH3A domain of intersectin-1s.
    J Cell Mol Med. 2011 Nov;15(11):2364-76 PMID: 21129155
  10. Caveolin regulates endocytosis of the muscle repair protein, dysferlin.
    J Biol Chem. 2008 Mar 7;283(10):6476-88 PMID: 18096699
  11. Molecular mechanism and physiological functions of clathrin-mediated endocytosis.
    Nat Rev Mol Cell Biol. 2011 Jul 22;12(8):517-33 PMID: 21779028
  12. Region and diagnosis-specific changes in synaptic proteins in schizophrenia and bipolar I disorder.
    Psychiatry Res. 2010 Jul 30;178(2):374-80 PMID: 20488553
  13. Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis.
    Methods Enzymol. 2008;438:77-93 PMID: 18413242
  14. Crystal structure of nucleotide-free dynamin.
    Nature. 2011 Sep 18;477(7366):556-60 PMID: 21927000
  15. Dynasore, an inhibitor of dynamin, increases the probability of transmitter release.
    Neuroscience. 2011 Jan 13;172:187-95 PMID: 21056636
  16. Ultrastructural identification of uncoated caveolin-independent early endocytic vehicles.
    J Cell Biol. 2005 Jan 31;168(3):465-76 PMID: 15668297
  17. HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes.
    Cell. 2009 May 1;137(3):433-44 PMID: 19410541
  18. The pthaladyns: GTP competitive inhibitors of dynamin I and II GTPase derived from virtual screening.
    J Med Chem. 2010 Jul 22;53(14):5267-80 PMID: 20575553
  19. Inhibition of dynamin by dynole 34-2 induces cell death following cytokinesis failure in cancer cells.
    Mol Cancer Ther. 2011 Sep;10(9):1553-62 PMID: 21750222
  20. Interaction of dynamin with microtubules: its structure and GTPase activity investigated by using highly purified dynamin.
    Mol Biol Cell. 1992 Oct;3(10):1181-94 PMID: 1421574
  21. Clathrin-independent carriers form a high capacity endocytic sorting system at the leading edge of migrating cells.
    J Cell Biol. 2010 Aug 23;190(4):675-91 PMID: 20713605
  22. Iminochromene inhibitors of dynamins I and II GTPase activity and endocytosis.
    J Med Chem. 2010 May 27;53(10):4094-102 PMID: 20426422
  23. The dynamin inhibitors MiTMAB and OcTMAB induce cytokinesis failure and inhibit cell proliferation in human cancer cells.
    Mol Cancer Ther. 2010 Jul;9(7):1995-2006 PMID: 20571068
  24. The Rhodadyns, a New Class of Small Molecule Inhibitors of Dynamin GTPase Activity.
    ACS Med Chem Lett. 2012 Mar 26;3(5):352-6 PMID: 24900478
  25. Direct dynamin-actin interactions regulate the actin cytoskeleton.
    EMBO J. 2010 Nov 3;29(21):3593-606 PMID: 20935625
  26. Microtubules and Src homology 3 domains stimulate the dynamin GTPase via its C-terminal domain.
    Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11468-72 PMID: 7505438
  27. Development of second-generation indole-based dynamin GTPase inhibitors.
    J Med Chem. 2013 Jan 10;56(1):46-59 PMID: 23167654
  28. Pyrimidyn compounds: dual-action small molecule pyrimidine-based dynamin inhibitors.
    ACS Chem Biol. 2013 Jul 19;8(7):1507-18 PMID: 23642287
  29. Small molecule inhibitors of dynamin I GTPase activity: development of dimeric tyrphostins.
    J Med Chem. 2005 Dec 1;48(24):7781-8 PMID: 16302817
  30. Comprehensive mechanistic analysis of hits from high-throughput and docking screens against beta-lactamase.
    J Med Chem. 2008 Apr 24;51(8):2502-11 PMID: 18333608
  31. Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition.
    Cell. 2011 Aug 5;146(3):471-84 PMID: 21816279
  32. Dynamin self-assembly stimulates its GTPase activity.
    J Biol Chem. 1996 Sep 13;271(37):22310-4 PMID: 8798389
  33. Inhibition of dynamin mediated endocytosis by the dynoles--synthesis and functional activity of a family of indoles.
    J Med Chem. 2009 Jun 25;52(12):3762-73 PMID: 19459681
  34. A selective activity-dependent requirement for dynamin 1 in synaptic vesicle endocytosis.
    Science. 2007 Apr 27;316(5824):570-4 PMID: 17463283
  35. The crystal structure of dynamin.
    Nature. 2011 Sep 18;477(7366):561-6 PMID: 21927001
  36. Myristyl trimethyl ammonium bromide and octadecyl trimethyl ammonium bromide are surface-active small molecule dynamin inhibitors that block endocytosis mediated by dynamin I or dynamin II.
    Mol Pharmacol. 2007 Dec;72(6):1425-39 PMID: 17702890
  37. Pre- and postsynaptic whole-cell recordings in the medial nucleus of the trapezoid body of the rat.
    J Physiol. 1995 Dec 15;489 ( Pt 3):825-40 PMID: 8788946
  38. High-throughput assays for promiscuous inhibitors.
    Nat Chem Biol. 2005 Aug;1(3):146-8 PMID: 16408018
  39. Specificity and mechanism of action of some commonly used protein kinase inhibitors.
    Biochem J. 2000 Oct 1;351(Pt 1):95-105 PMID: 10998351
  40. Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity.
    J Pharm Sci. 2003 Nov;92(11):2236-48 PMID: 14603509
  41. Isoform and splice-variant specific functions of dynamin-2 revealed by analysis of conditional knock-out cells.
    Mol Biol Cell. 2008 Dec;19(12):5347-59 PMID: 18923138
  42. Cell- and stimulus-dependent heterogeneity of synaptic vesicle endocytic recycling mechanisms revealed by studies of dynamin 1-null neurons.
    Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2175-80 PMID: 18250322
  43. GTP-independent rapid and slow endocytosis at a central synapse.
    Nat Neurosci. 2008 Jan;11(1):45-53 PMID: 18066059
  44. Effect of detergent on "promiscuous" inhibitors.
    J Med Chem. 2003 Jul 31;46(16):3448-51 PMID: 12877581
  45. Identification of small-molecule inhibitors of protein kinase B (PKB/AKT) in an AlphaScreenTM high-throughput screen.
    J Biomol Screen. 2006 Oct;11(7):822-7 PMID: 16902245
  46. The phospho-dependent dynamin-syndapin interaction triggers activity-dependent bulk endocytosis of synaptic vesicles.
    J Neurosci. 2009 Jun 17;29(24):7706-17 PMID: 19535582
  47. Syndapin I is the phosphorylation-regulated dynamin I partner in synaptic vesicle endocytosis.
    Nat Neurosci. 2006 Jun;9(6):752-60 PMID: 16648848
  48. A rapid Percoll gradient procedure for preparation of synaptosomes.
    Nat Protoc. 2008;3(11):1718-28 PMID: 18927557
  49. Dimeric endophilin A2 stimulates assembly and GTPase activity of dynamin 2.
    Biophys J. 2011 Feb 2;100(3):729-737 PMID: 21281588
  50. Long chain amines and long chain ammonium salts as novel inhibitors of dynamin GTPase activity.
    Bioorg Med Chem Lett. 2004 Jun 21;14(12):3275-8 PMID: 15149689
  51. Cdk5 is essential for synaptic vesicle endocytosis.
    Nat Cell Biol. 2003 Aug;5(8):701-10 PMID: 12855954
  52. Analysis of synaptic vesicle endocytosis in synaptosomes by high-content screening.
    Nat Protoc. 2012 Jul 05;7(8):1439-55 PMID: 22767087
  53. A model for dynamin self-assembly based on binding between three different protein domains.
    J Biol Chem. 1999 May 21;274(21):14942-7 PMID: 10329695
  54. Ubiquitously expressed dynamin-II has a higher intrinsic GTPase activity and a greater propensity for self-assembly than neuronal dynamin-I.
    Mol Biol Cell. 1997 Dec;8(12):2553-62 PMID: 9398675
  55. Characterization of the urinary albumin degradation pathway in the isolated perfused rat kidney.
    J Lab Clin Med. 2006 Jan;147(1):36-44 PMID: 16443003
  56. An assembly-incompetent mutant establishes a requirement for dynamin self-assembly in clathrin-mediated endocytosis in vivo.
    Mol Biol Cell. 2004 May;15(5):2243-52 PMID: 15004222
  57. Dynamin self-assembles into rings suggesting a mechanism for coated vesicle budding.
    Nature. 1995 Mar 9;374(6518):190-2 PMID: 7877694
  58. Dynamin regulates specific membrane fusion events necessary for acrosomal exocytosis in mouse spermatozoa.
    J Biol Chem. 2012 Nov 2;287(45):37659-72 PMID: 22977254
  59. A high-throughput screen for aggregation-based inhibition in a large compound library.
    J Med Chem. 2007 May 17;50(10):2385-90 PMID: 17447748
  60. Azido and diazarinyl analogues of bis-tyrphostin as asymmetrical inhibitors of dynamin GTPase.
    ChemMedChem. 2009 Jul;4(7):1182-8 PMID: 19437476
  61. Dynamin inhibitors induce caspase-mediated apoptosis following cytokinesis failure in human cancer cells and this is blocked by Bcl-2 overexpression.
    Mol Cancer. 2011 Jun 28;10:78 PMID: 21708043
  62. The dynamin middle domain is critical for tetramerization and higher-order self-assembly.
    EMBO J. 2007 Jan 24;26(2):559-66 PMID: 17170701
  63. Some selective serotonin reuptake inhibitors inhibit dynamin I guanosine triphosphatase (GTPase).
    Biol Pharm Bull. 2008 Aug;31(8):1489-95 PMID: 18670077
Article Info
Journal
Traffic (Copenhagen, Denmark)
Abbr.
Traffic
ISSN
1600-0854
Published
2013-12-00
Epub
2013-00-09
Pages
1272-89
Language
English
Region
England
NLM ID
100939340
PMCID
PMC4138991
Subset
IM
Grants
Wellcome Trust · United Kingdom
Wellcome Trust · 084277 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com